Trump's proposed tariffs may raise drug prices and cause shortages, impacting the U.S. pharmaceutical market by increasing the cost and availability of medications.
India's Foreign Portfolio Investment plummeted 99% to just Rs 2026 crore in 2024, influenced by the strong US economy and local market underperformance.